Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kymera Therapeutics, Inc. (KYMR) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kymera Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1815442.
Total stock buying since 2021: $112,392,474.
Total stock sales since 2021: $177,905,451.
Total stock option exercises since 2021: $4,875,775.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 972,667 | $42,797,348 | 77,377 | $3,439,821 | 102,849 | $792,743 |
| 2024 | 0 | $0 | 1,458,542 | $58,840,761 | 197,423 | $972,621 |
| 2023 | 414,105 | $5,301,258 | 3,382 | $105,303 | 42,000 | $87,360 |
| 2022 | 1,498,127 | $38,718,066 | 1,080,436 | $34,075,954 | 252,732 | $517,980 |
| 2021 | 544,166 | $25,575,802 | 1,416,229 | $81,443,612 | 456,373 | $2,505,071 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 972,667 | $42,797,348 | 57,849 | $2,806,286 | 57,849 | $699,143 |
| 2025-03 | 0 | $0 | 16,399 | $502,890 | 25,000 | $52,000 |
| 2025-01 | 0 | $0 | 3,129 | $130,645 | 20,000 | $41,600 |
| 2024-12 | 0 | $0 | 2,500 | $122,500 | 2,500 | $73,875 |
| 2024-09 | 0 | $0 | 13,500 | $651,361 | 13,500 | $295,177 |
| 2024-08 | 0 | $0 | 5,000 | $245,509 | 5,000 | $51,700 |
| 2024-07 | 0 | $0 | 493,560 | $18,793,007 | 58,373 | $182,427 |
| 2024-06 | 0 | $0 | 35,440 | $1,233,607 | 47,913 | $99,659 |
| 2024-05 | 0 | $0 | 2,575 | $90,104 | 0 | $0 |
| 2024-03 | 0 | $0 | 841,535 | $35,485,505 | 0 | $0 |
| 2024-02 | 0 | $0 | 51,137 | $1,844,284 | 51,137 | $147,663 |
| 2024-01 | 0 | $0 | 13,295 | $374,884 | 19,000 | $122,120 |
| 2023-11 | 414,105 | $5,301,258 | 0 | $0 | 20,000 | $41,600 |
| 2023-08 | 0 | $0 | 0 | $0 | 12,000 | $24,960 |
| 2023-06 | 0 | $0 | 0 | $0 | 10,000 | $20,800 |
| 2023-03 | 0 | $0 | 3,382 | $105,303 | 0 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 30,000 | $62,400 |
| 2022-11 | 0 | $0 | 594,092 | $17,954,802 | 0 | $0 |
| 2022-10 | 0 | $0 | 423,344 | $12,755,806 | 79,732 | $165,842 |
| 2022-08 | 545,525 | $14,183,650 | 0 | $0 | 0 | $0 |
| 2022-05 | 549,526 | $9,157,162 | 0 | $0 | 60,000 | $117,100 |
| 2022-01 | 403,076 | $15,377,254 | 63,000 | $3,365,346 | 83,000 | $172,638 |
| 2021-12 | 0 | $0 | 10,000 | $542,320 | 18,000 | $37,440 |
| 2021-11 | 0 | $0 | 57,493 | $3,581,909 | 49,603 | $93,699 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-30 | Lampert Mark N | Buy | 317,167 | 44.00 | 13,955,348 |
| 2025-06-30 | Baker Julian | Buy | 655,500 | 44.00 | 28,842,000 |
| 2025-06-11 | Ridloff Elena | Sale | 4,500 | 50.00 | 225,000 |
| 2025-06-11 | Ridloff Elena | Option Ex | 4,500 | 20.29 | 91,305 |
| 2025-06-03 | Mainolfi Nello (Chief Executive Officer) | Sale | 30,000 | 49.00 | 1,470,000 |
| 2025-06-03 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 30,000 | 2.08 | 62,400 |
| 2025-06-03 | Ridloff Elena | Sale | 12,000 | 46.25 | 555,000 |
| 2025-06-03 | Ridloff Elena | Option Ex | 12,000 | 27.67 | 332,040 |
| 2025-06-03 | Esposito Pamela | Sale | 5,000 | 49.04 | 245,185 |
| 2025-06-03 | Esposito Pamela | Option Ex | 5,000 | 29.55 | 147,750 |
| 2025-06-03 | Albers Jeffrey W. | Sale | 6,349 | 49.00 | 311,101 |
| 2025-06-03 | Albers Jeffrey W. | Option Ex | 6,349 | 10.34 | 65,648 |
| 2025-03-31 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 25,000 | 2.08 | 52,000 |
| 2025-03-03 | Gollob Jared (Chief Medical Officer) | Sale | 5,740 | 30.67 | 176,022 |
| 2025-03-03 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 7,035 | 30.67 | 215,735 |
| 2025-03-03 | Chiniara Ellen (Chief Legal Officer) | Sale | 2,241 | 30.67 | 68,722 |
| 2025-03-03 | Chadwick Jeremy G (Chief Operating Officer) | Sale | 1,383 | 30.67 | 42,411 |
| 2025-01-10 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2025-01-10 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2025-01-06 | Chiniara Ellen (Chief Legal Officer) | Sale | 3,129 | 41.75 | 130,645 |
| 2024-12-02 | Esposito Pamela | Sale | 2,500 | 49.00 | 122,500 |
| 2024-12-02 | Esposito Pamela | Option Ex | 2,500 | 29.55 | 73,875 |
| 2024-09-17 | Esposito Pamela | Sale | 13,500 | 48.25 | 651,361 |
| 2024-09-17 | Esposito Pamela | Option Ex | 13,500 | 21.86 | 295,177 |
| 2024-08-26 | Albers Jeffrey W. | Sale | 5,000 | 49.10 | 245,509 |
| 2024-08-26 | Albers Jeffrey W. | Option Ex | 5,000 | 10.34 | 51,700 |
| 2024-07-16 | Gollob Jared (Chief Medical Officer) | Sale | 23,145 | 45.84 | 1,061,082 |
| 2024-07-16 | Gollob Jared (Chief Medical Officer) | Option Ex | 23,145 | 2.08 | 48,141 |
| 2024-07-15 | Gollob Jared (Chief Medical Officer) | Sale | 16,455 | 45.15 | 742,926 |
| 2024-07-15 | Gollob Jared (Chief Medical Officer) | Option Ex | 16,455 | 2.08 | 34,226 |
| 2024-07-09 | Booth Bruce | Sale | 453,960 | 37.42 | 16,988,999 |
| 2024-07-01 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 18,773 | 5.33 | 100,060 |
| 2024-06-27 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 25,000 | 2.08 | 52,000 |
| 2024-06-18 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 14,413 | 2.08 | 29,979 |
| 2024-06-13 | Booth Bruce | Sale | 10,200 | 34.98 | 356,795 |
| 2024-06-12 | Booth Bruce | Sale | 16,740 | 35.69 | 597,366 |
| 2024-06-07 | Horobin Joanna | Sale | 8,500 | 32.88 | 279,446 |
| 2024-06-07 | Horobin Joanna | Option Ex | 8,500 | 2.08 | 17,680 |
| 2024-05-23 | Chadwick Jeremy G (Chief Operating Officer) | Sale | 2,575 | 34.99 | 90,104 |
| 2024-03-15 | Booth Bruce | Sale | 71,764 | 40.39 | 2,898,332 |
| 2024-03-14 | Booth Bruce | Sale | 55,779 | 40.63 | 2,266,468 |
| 2024-03-13 | Atlas Venture Associates Opportunity I, Llc | Sale | 139,255 | 42.52 | 5,920,426 |
| 2024-03-13 | Booth Bruce | Sale | 139,255 | 42.52 | 5,920,426 |
| 2024-03-12 | Atlas Venture Associates Opportunity I, Llc | Sale | 162,918 | 42.23 | 6,880,027 |
| 2024-03-12 | Booth Bruce | Sale | 162,918 | 42.23 | 6,880,027 |
| 2024-03-11 | Atlas Venture Associates Opportunity I, Llc | Sale | 51,184 | 43.09 | 2,205,774 |
| 2024-03-11 | Booth Bruce | Sale | 51,184 | 43.09 | 2,205,774 |
| 2024-03-04 | Gollob Jared (Chief Medical Officer) | Sale | 3,344 | 42.35 | 141,631 |
| 2024-03-04 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 3,934 | 42.35 | 166,620 |
| 2024-02-21 | Albers Jeffrey W. | Sale | 4,385 | 39.05 | 171,225 |
| 2024-02-21 | Albers Jeffrey W. | Option Ex | 4,385 | 10.34 | 45,340 |
| 2024-02-20 | Albers Jeffrey W. | Sale | 615 | 39.08 | 24,031 |
| 2024-02-20 | Albers Jeffrey W. | Option Ex | 615 | 10.34 | 6,359 |
| 2024-02-09 | Gollob Jared (Chief Medical Officer) | Sale | 46,137 | 35.74 | 1,649,028 |
| 2024-02-09 | Gollob Jared (Chief Medical Officer) | Option Ex | 46,137 | 2.08 | 95,964 |
| 2024-01-23 | Albers Jeffrey W. | Sale | 10,000 | 30.05 | 300,470 |
| 2024-01-23 | Albers Jeffrey W. | Option Ex | 10,000 | 10.34 | 103,400 |
| 2024-01-04 | Chiniara Ellen (Chief Legal Officer) | Sale | 3,295 | 22.58 | 74,414 |
| 2024-01-02 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 9,000 | 2.08 | 18,720 |
| 2023-11-03 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 20,000 | 2.08 | 41,600 |
| 2023-11-03 | Lampert Mark N | Buy | 197,699 | 14.07 | 2,781,427 |
| 2023-11-02 | Lampert Mark N | Buy | 216,406 | 11.64 | 2,519,831 |
| 2023-08-08 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 12,000 | 2.08 | 24,960 |
| 2023-06-02 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2023-03-02 | Caughey Elaine (Chief Business Officer) | Sale | 714 | 31.14 | 22,231 |
| 2023-03-02 | Gollob Jared (Chief Medical Officer) | Sale | 1,298 | 31.14 | 40,415 |
| 2023-03-02 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 1,370 | 31.14 | 42,657 |
| 2022-12-08 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 20,000 | 2.08 | 41,600 |
| 2022-11-03 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 96,397 | 30.00 | 2,891,910 |
| 2022-11-03 | Booth Bruce (Director) | Sale | 96,397 | 30.00 | 2,891,910 |
| 2022-11-02 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 123,619 | 30.02 | 3,711,042 |
| 2022-11-02 | Booth Bruce (Director) | Sale | 123,619 | 30.02 | 3,711,042 |
| 2022-11-01 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 77,030 | 30.82 | 2,374,449 |
| 2022-11-01 | Booth Bruce (Director) | Sale | 77,030 | 30.82 | 2,374,449 |
| 2022-10-31 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 120,622 | 30.23 | 3,646,403 |
| 2022-10-31 | Booth Bruce (Director) | Sale | 120,622 | 30.23 | 3,646,403 |
| 2022-10-28 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 91,050 | 30.00 | 2,731,500 |
| 2022-10-28 | Booth Bruce (Director) | Sale | 91,050 | 30.00 | 2,731,500 |
| 2022-10-21 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2022-10-17 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 59,732 | 2.08 | 124,242 |
| 2022-10-17 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2022-08-22 | Lampert Mark N | Buy | 545,525 | 26.00 | 14,183,650 |
| 2022-05-27 | Lampert Mark N | Buy | 65,369 | 14.78 | 966,349 |
| 2022-05-26 | Lampert Mark N | Buy | 224,057 | 14.21 | 3,184,074 |
| 2022-05-20 | Lampert Mark N | Buy | 10,100 | 14.00 | 141,389 |
| 2022-05-06 | Lampert Mark N | Buy | 100,000 | 19.25 | 1,925,500 |
| 2022-05-05 | Lampert Mark N | Buy | 150,000 | 19.60 | 2,939,850 |
| 2022-05-04 | Gollob Jared (Chief Medical Officer) | Option Ex | 20,000 | 1.70 | 33,900 |
| 2022-05-03 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 20,000 | 2.08 | 41,600 |
| 2022-05-03 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 20,000 | 2.08 | 41,600 |
| 2022-01-31 | Lampert Mark N | Buy | 34,408 | 40.70 | 1,400,405 |
| 2022-01-27 | Lampert Mark N | Buy | 95,901 | 38.33 | 3,676,077 |
| 2022-01-24 | Lampert Mark N | Buy | 272,767 | 37.76 | 10,300,772 |
| 2022-01-14 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2022-01-14 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2022-01-12 | Mainolfi Nello (Chief Executive Officer) | Sale | 8,612 | 52.64 | 453,352 |
| 2022-01-12 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 8,612 | 2.08 | 17,912 |
| 2022-01-12 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 15,000 | 52.20 | 783,060 |
| 2022-01-12 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2022-01-11 | Mainolfi Nello (Chief Executive Officer) | Sale | 16,923 | 54.38 | 920,340 |
| 2022-01-11 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 16,923 | 2.08 | 35,199 |
| 2022-01-10 | Mainolfi Nello (Chief Executive Officer) | Sale | 22,465 | 53.80 | 1,208,594 |
| 2022-01-10 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 22,465 | 2.08 | 46,727 |
| 2021-12-16 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 8,000 | 2.08 | 16,640 |
| 2021-12-03 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 10,000 | 54.23 | 542,320 |
| 2021-12-03 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-11-23 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-11-02 | Gollob Jared (Chief Medical Officer) | Sale | 14,996 | 63.58 | 953,385 |
| 2021-11-02 | Gollob Jared (Chief Medical Officer) | Option Ex | 14,996 | 2.08 | 31,191 |
| 2021-11-01 | Gollob Jared (Chief Medical Officer) | Sale | 42,497 | 61.85 | 2,628,524 |
| 2021-11-01 | Gollob Jared (Chief Medical Officer) | Option Ex | 24,607 | 1.70 | 41,708 |
| 2021-10-11 | Mainolfi Nello (Chief Executive Officer) | Sale | 6,456 | 54.04 | 348,875 |
| 2021-10-11 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 6,456 | 2.08 | 13,428 |
| 2021-10-08 | Mainolfi Nello (Chief Executive Officer) | Sale | 41,544 | 58.52 | 2,431,279 |
| 2021-10-08 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 41,544 | 2.08 | 86,411 |
| 2021-09-03 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 10,000 | 60.27 | 602,740 |
| 2021-09-03 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-08-27 | Chesworth Richard (Chief Scientific Officer) | Sale | 33,779 | 60.12 | 2,030,861 |
| 2021-08-27 | Chesworth Richard (Chief Scientific Officer) | Option Ex | 33,779 | 20.00 | 675,580 |
| 2021-08-19 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 12,000 | 2.08 | 24,960 |
| 2021-08-17 | Chesworth Richard (Chief Scientific Officer) | Sale | 54,000 | 51.01 | 2,754,648 |
| 2021-08-17 | Chesworth Richard (Chief Scientific Officer) | Option Ex | 54,000 | 20.00 | 1,080,000 |
| 2021-08-11 | Atlas Venture Associates X, Llc (10% Owner) | Sale | 242,133 | 61.00 | 14,770,113 |
| 2021-08-11 | Booth Bruce (Director) | Sale | 242,133 | 61.00 | 14,770,113 |
| 2021-08-04 | Mainolfi Nello (Chief Executive Officer) | Sale | 1,037 | 60.03 | 62,253 |
| 2021-08-04 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 1,037 | 2.08 | 2,156 |
| 2021-08-03 | Mainolfi Nello (Chief Executive Officer) | Sale | 5,669 | 60.07 | 340,531 |
| 2021-08-03 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 5,669 | 2.08 | 11,791 |
| 2021-08-02 | Mainolfi Nello (Chief Executive Officer) | Sale | 23,456 | 61.23 | 1,436,210 |
| 2021-08-02 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 23,456 | 2.08 | 48,788 |
| 2021-07-30 | Mainolfi Nello (Chief Executive Officer) | Sale | 6,279 | 60.07 | 377,166 |
| 2021-07-30 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 6,279 | 2.08 | 13,060 |
| 2021-07-29 | Mainolfi Nello (Chief Executive Officer) | Sale | 680 | 60.00 | 40,800 |
| 2021-07-29 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 680 | 2.08 | 1,414 |
| 2021-07-28 | Mainolfi Nello (Chief Executive Officer) | Sale | 3,864 | 60.15 | 232,408 |
| 2021-07-28 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 3,864 | 2.08 | 8,037 |
| 2021-07-26 | Mainolfi Nello (Chief Executive Officer) | Sale | 9,015 | 60.15 | 542,234 |
| 2021-07-26 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 9,015 | 2.08 | 18,751 |
| 2021-07-08 | Mainolfi Nello (Chief Executive Officer) | Sale | 48,000 | 50.37 | 2,417,520 |
| 2021-07-08 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 48,000 | 2.08 | 99,840 |
| 2021-07-01 | Lampert Mark N | Buy | 544,166 | 47.00 | 25,575,802 |
| 2021-06-09 | Mainolfi Nello (Chief Executive Officer) | Sale | 5,752 | 50.02 | 287,720 |
| 2021-06-09 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 5,752 | 2.08 | 11,964 |
| 2021-06-08 | Mainolfi Nello (Chief Executive Officer) | Sale | 270 | 50.00 | 13,500 |
| 2021-06-08 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 270 | 2.08 | 561 |
| 2021-06-07 | Mainolfi Nello (Chief Executive Officer) | Sale | 12,724 | 50.15 | 638,044 |
| 2021-06-07 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 12,724 | 2.08 | 26,465 |
| 2021-05-19 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2021-05-12 | Mainolfi Nello (Chief Executive Officer) | Sale | 8,245 | 50.05 | 412,678 |
| 2021-05-12 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 8,245 | 2.08 | 17,149 |
| 2021-04-26 | Mainolfi Nello (Chief Executive Officer) | Sale | 2,768 | 40.18 | 111,229 |
| 2021-04-26 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 2,768 | 2.08 | 5,757 |
| 2021-04-23 | Mainolfi Nello (Chief Executive Officer) | Sale | 680 | 40.01 | 27,207 |
| 2021-04-23 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 680 | 2.08 | 1,414 |
| 2021-04-22 | Mainolfi Nello (Chief Executive Officer) | Sale | 10,959 | 40.26 | 441,187 |
| 2021-04-22 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 10,959 | 2.08 | 22,794 |
| 2021-04-19 | Mainolfi Nello (Chief Executive Officer) | Sale | 653 | 40.00 | 26,120 |
| 2021-04-19 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 6,653 | 2.08 | 13,838 |
| 2021-04-15 | Mainolfi Nello (Chief Executive Officer) | Sale | 4,940 | 40.29 | 199,037 |
| 2021-04-15 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 4,940 | 2.08 | 10,275 |
| 2021-04-13 | Mainolfi Nello (Chief Executive Officer) | Option Ex | 15,000 | 2.08 | 31,200 |
| 2021-03-15 | Gollob Jared (Chief Medical Officer) | Sale | 10,305 | 60.17 | 620,051 |
| 2021-03-15 | Gollob Jared (Chief Medical Officer) | Option Ex | 7,800 | 1.31 | 10,218 |
| 2021-03-15 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 8,195 | 60.17 | 493,093 |
| 2021-03-15 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 8,195 | 2.08 | 17,045 |
| 2021-03-12 | Atlas Venture Associates X, Llc (10% Owner) | Sale | 229,350 | 56.50 | 12,958,275 |
| 2021-03-12 | Booth Bruce (Director) | Sale | 229,350 | 56.50 | 12,958,275 |
| 2021-03-11 | Gollob Jared (Chief Medical Officer) | Sale | 4,695 | 60.05 | 281,939 |
| 2021-03-11 | Gollob Jared (Chief Medical Officer) | Option Ex | 2,200 | 1.31 | 2,882 |
| 2021-03-11 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 1,805 | 60.07 | 108,431 |
| 2021-03-11 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 1,805 | 2.08 | 3,754 |
| 2021-03-08 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 10,000 | 51.30 | 512,950 |
| 2021-03-08 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 10,000 | 2.08 | 20,800 |
| 2021-03-03 | Jacobs Bruce N. (Chief Financial Officer) | Sale | 20,000 | 44.98 | 899,599 |
| 2021-03-03 | Jacobs Bruce N. (Chief Financial Officer) | Option Ex | 20,000 | 2.08 | 41,600 |
| 2021-02-24 | Gollob Jared (Chief Medical Officer) | Sale | 8,675 | 50.91 | 441,670 |
| 2021-02-23 | Gollob Jared (Chief Medical Officer) | Sale | 19,285 | 49.65 | 957,558 |
| 2021-02-22 | Gollob Jared (Chief Medical Officer) | Sale | 9,104 | 52.63 | 479,134 |
| 2021-02-19 | Gollob Jared (Chief Medical Officer) | Sale | 8,887 | 55.09 | 489,558 |
| 2021-02-18 | Gollob Jared (Chief Medical Officer) | Sale | 6,499 | 55.94 | 363,541 |
| 2021-02-17 | Gollob Jared (Chief Medical Officer) | Sale | 7,550 | 58.39 | 440,836 |
Insider trading activities including stock purchases, stock sales, and option exercises of KYMR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kymera Therapeutics, Inc. (symbol KYMR, CIK number 1815442) see the Securities and Exchange Commission (SEC) website.